Effects of ursolic acid derivatives on Caco-2 cells and their alleviating role in streptozocin-induced type 2 diabetic rats

Molecules

Volumn 19, Issue 8, 2014, Pages 12559-12576

  Wu, Panpan ^a   He, Ping ^a   Zhao, Suqing ^a   Huang, Tianming ^a   Lu, Yujing ^a   Zhang, Kun ^a  

^a GUANGDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

2 NBDG.; Caco 2 cell; Diabetes mellitus; Streptozotocin (STZ) induced diabetic rat; Ursolic acid derivatives

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORTER 2; SLC2A2 PROTEIN, HUMAN; SLC5A1 PROTEIN, HUMAN; SODIUM GLUCOSE COTRANSPORTER 1; STREPTOZOCIN; TRITERPENE; URSOLIC ACID;

ANIMAL; BLOOD; CACO 2 CELL LINE; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; DRUG SCREENING; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; OXIDATIVE STRESS; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; CACO-2 CELLS; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, EXPERIMENTAL; DRUG EVALUATION, PRECLINICAL; GLUCOSE; GLUCOSE TRANSPORTER TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; MALE; OXIDATIVE STRESS; RATS, SPRAGUE-DAWLEY; SODIUM-GLUCOSE TRANSPORTER 1; STREPTOZOCIN; TRITERPENES;

EID: 84906707091     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190812559     Document Type: Article

References (56)

1. WHO. "Fact Sheet # 312" to Be Found under. Available online: http://www.who.int/mediacentre/factsheets/fs312/en/ (accessed on 15 December 2013).
2. Tuomilehto, J.; Lindström, J.; Eriksson, J.G.; Valle, T.T.; Hämäläinen, H.; Ilanne-Parikka, P.; Keinänen-Kiukaanniemi, S.; Laakso, M.; Louheranta, A.; Rastas, M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 2001, 344, 1343-1350.
3. Zimmet, P.; Alberti, K.G.; Shaw, J. Global and societal implications of the diabetes epidemic. Nature 2001, 414, 782-787.
4. Lopez-Candales, A. Metabolic syndrome X: A comprehensive review of the pathophysiology and recommended therapy. J. Med. 2001, 32, 283-300.
5. Hays, N.P.; Galassetti, P.R.; Coker, R.H. Prevention and treatment of type 2 diabetes: Current role of lifestyle, natural product, and pharmacological interventions. Pharmacol. Ther. 2008, 118, 181-191.
6. Hung, H.Y.; Qian, K.; Morris-Natschke, S.L.; Hsu, C.S.; Lee, K.H. Recent discovery of plant-derived anti-diabetic natural products. Nat. Prod. Rep. 2012, 29, 580-606.
7. Jia, W.; Gao, W.; Tang, L. Antidiabetic herbal drugs officially approved in China. Phytother. Res. 2003, 17, 1127-1134.
8. Roglic, G.; Unwin, N.; Bennett, P.H.; Mathers, C.; Tuomilehto, J.; Nag, S.; Connolly, V.; King, H. The burden of mortality attributable to diabetes: Realistic estimates for the year 2000. Diabetes Care 2005, 28, 2130-2135.
9. Harmand, P.O.; Duval, R.; Delage, C.; Simon, A. Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells. Int. J. Cancer 2005, 114, 1-11.
10. Kim, D.K.; Baek, J.H.; Kang, C.M.; Yoo, M.; Sung, J.W.; Kim, D.K.; Chung, H.Y.; Kim, N.D.; Choi, Y.H.; Lee, S.H. Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication. Int. J. Cancer 2000, 87, 629-636.
11. Baricevic, D.; Sosa, S.; Della, L.R.; Tubaro, A.; Simonovska, B.; Krasna, A.; Zupancic, A. Topical anti-inflammatory activity of Salvia officinalis L. leaves: The relevance of ursolic acid. J. Ethnopharmacol. 2001, 75, 125-132.
12. Kazmi, I.; Rahman, M.; Afzal, M.; Gupta, G.; Saleem, S.; Afzal, O.; Shaharyar, M.A.; Nautiyal, U.; Ahmed, S.; Anwar, F. Anti-diabetic potential of ursolic acid stearoyl glucoside: A new triterpenic gycosidic ester from Lantana camara. Fitoterapia 2012, 83, 142-146.
13. Ullevig, S.L.; Zhao, Q.; Zamora, D.; Asmis, R. Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis. Atherosclerosis 2011, 219, 409-416.
14. Zhou, Y.; Li, J.S.; Zhang, X.; Wu, Y.J.; Huang, K.; Zheng, L. Ursolic acid inhibits early lesions of diabetic nephropathy. Int. J. Mol. Med. 2010, 26, 565-570.
15. Zou, C.; Wang, Y.; Shen, Z. 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J. Biochem. Biophys. Methods 2005, 64, 207-215.
16. Yamada, K.; Saito, M.; Matsuoka, H.; Inagaki, N. A real-time method of imaging glucose uptake in single, living mammalian cells. Nat. Protoc. 2007, 2, 753-762.
17. Hassanein, M.; Weidow, B.; Koehler, E.; Bakane, N.; Garbett, S.; Shyr, Y.; Quaranta, V. Development of high-throughput quantitative assays for glucose uptake in cancer cell lines. Mol. Imaging Biol. 2011, 13, 840-852.
18. Nistor, B.L.; Martineau, L.C.; Benhaddou-Andaloussi, A.; Arnason, J.T.; Levy, E.; Haddad, P.S. Inhibition of intestinal glucose absorption by anti-diabetic medicinal plants derived from the James Bay Cree traditional pharmacopeia. J. Ethnopharmacol. 2010, 132, 473-482.
19. Kim, H.K.; Baek, S.S.; Cho, H.Y. Inhibitory effect of pomegranate on intestinal sodium dependent glucose uptake. Am. J. Chin. Med. 2011, 39, 1015-1027.
20. Haidara, M.A.; Yassin, H.Z.; Rateb, M.; Ammar, H.; Zorkani, M.A. Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. Curr. Vasc. Pharmacol. 2006, 4, 215-227.
21. Pitozzi, V.; Giovannelli, L.; Bardini, G.; Rotella, C.M.; Dolara, P. Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: Higher vulnerability of polymorphonuclear leukocytes. Mutat. Res. 2003, 529, 129-133.
22. Evans, J.L. Antioxidants: Do they have a role in the treatment of insulin resistance? Indian J. Med. Res. 2007, 125, 355-372.
23. Wu, P.P.; Zhang, K.; Lu, Y.J.; He, P.; Zhao, S.Q. In vitro and in vivo evaluation of the antidiabetic activity of ursolic acid derivatives. Eur. J. Med. Chem. 2014, 80, 502-508.
24. Sambuy, Y.; de Angelis, I.; Ranaldi, G.; Scarino, M.L.; Stammati, A.; Zucco, F. The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell. Biol. Toxicol. 2005, 21, 1-26.
25. Delie, F.; Rubas, W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Drug Carrier Syst. 1997, 14, 221-286.
26. Mahraoui, L.; Rodolosse, A.; Barbat, A.; Dussaulx, E.; Zweibaum, A.; Rousset, M.; Brot-Laroche, E. Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption. Biochem. J. 1994, 298, 629-633.
27. Jang, S.M.; Yee, S.T.; Choi, J.; Choi, M.S.; Do, G.M.; Jeon, S.M.; Yeo, J.; Kim, M.J.; Seo, K.I.; Lee, M.K. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet. Int. Immunopharmacol. 2009, 9, 113-119.
28. Jang, S.M.; Kim, M.J.; Choi, M.S.; Kwon, E.Y.; Lee, M.K. Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice. Metabolism 2010, 59, 512-519.
29. Arya, A.; Looi, C.Y.; Cheah, S.C.; Mustafa, M.R.; Mohd, M.A. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, beta-TC6 and its alleviating role in type 2 diabetic rats. J. Ethnopharmacol. 2012, 144, 22-32.
30. Poitout, V.; Stout, L.E.; Armstrong, M.B.; Walseth, T.F.; Sorenson, R.L.; Robertson, R.P. Morphological and functional characterization of beta TC-6 cells-an insulin-secreting cell line derived from transgenic mice. Diabetes 1995, 44, 306-313.
31. Yamada, K.; Nakata, M.; Horimoto, N.; Saito, M.; Matsuoka, H.; Inagaki, N. Measurement of glucose uptake and intracellular calcium concentration in single, living pancreatic beta-cells. J. Biol. Chem. 2000, 275, 22278-22283.
32. Masumoto, S.; Akimoto, Y.; Oike, H.; Kobori, M. Dietary phloridzin reduces blood glucose levels and reverses Sglt1 expression in the small intestine in streptozotocin-induced diabetic mice. J. Agric. Food. Chem. 2009, 57, 4651-4656.
33. Goto, T.; Horita, M.; Nagai, H.; Nagatomo, A.; Nishida, N.; Matsuura, Y.; Nagaoka, S. Tiliroside, a glycosidic flavonoid, inhibits carbohydrate digestion and glucose absorption in the gastrointestinal tract. Mol. Nutr. Food Res. 2012, 56, 435-445.
34. Kellett, G.L.; Brot-Laroche, E.; Mace, O.J.; Leturque, A. Sugar absorption in the intestine: The role of GLUT2. A. Leturque. Annu. Rev. Nutr. 2008, 28, 35-54.
35. Brown, G.K. Glucose transporters: Structure, function and consequences of deficiency. Metab. Dis. 2000, 23, 237-246.
36. Manzano, S.; Williamson, G. Polyphenols and phenolic acids from strawberry and apple decrease glucose uptake and transport by human intestinal Caco-2 cells. Mol. Nutr. Food Res. 2010, 54, 1773-1780.
37. Kellett, G.L.; Brot-Laroche, E. Apical GLUT2: A major pathway of intestinal sugar absorption. Diabetes 2005, 54, 3056-3062.
38. Almdal, T.P.; Vilstrup, H. Strict insulin therapy normalises organ nitrogen contents and the capacity of urea nitrogen synthesis in experimental diabetes in rats. Diabetologia 1988, 31, 114-118.
39. Knopp, R.H.; Retzlaff, B.; Aikawa, K.; Kahn, S.E. Management of patients with diabetic hyperlipidemia. Am. J. Cardiol. 2003, 91 (Suppl. 1), 24-28.
40. Kavalali, G.; Tuncel, H.; Goksel, S.; Hatemi, H.H. Hypoglycemic activity of Urtica pilulifera in streptozotocin-diabetic rats. J. Ethnopharmacol. 2003, 84, 241-245.
41. Cemek, M.; Kaga, S.; Simsek, N.; Buyukokuroglu, M.E.; Konuk, M. Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats. J. Nat. Med. 2008, 62, 284-293.
42. Fang, Y.Z.; Yang, S.; Wu, G. Free radicals, antioxidants, and nutrition. Nutrition 2002, 18, 872-879.
43. Griesmacher, A.; Kindhauser, M.; Andert, S.E.; Schreiner, W.; Toma, C.; Knoebl, P.; Pietschmann, P.; Prager, R.; Schnack, C.; Schernthaner, G.; et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am. J. Med. 1995, 98, 469-475.
44. Dewanjee, S.; Das, A.K.; Sahu, R.; Gangopadhyay, M. Antidiabetic activity of Diospyros peregrina fruit: effect on hyperglycemia, hyperlipidemia and augmented oxidative stress in experimental type 2 diabetes. Food Chem. Toxicol. 2009, 47, 2679-2685.
45. Blake, D.R.; Allen, R.E.; Lunec, J. Free radicals in biological systems - A review orientated to inflammatory processes. Br. Med. Bull. 1987, 43, 371-385.
46. Lin, Y.F.; Tsai, H.L.; Lee, Y.C.; Chang, S.J. Maternal vitamin E supplementation affects the antioxidant capability and oxidative status of hatching chicks. J. Nutr. 2005, 135, 2457-2461.
47. Carr, M.C.; Brunzell, J.D. Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J. Clin. Endocrinol. Metab. 2004, 89, 2601-2607.
48. Yoshihara, T.; Kumashiro, N.; Kanazawa, Y.; Mita, T.; Sakurai, Y.; Kawai, J.; Abe, M.; Motojima, K.; Hara, K.; Yamazaki, Y.; et al. Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus. Endocr. J. 2006, 53, 67-72.
49. Burnette, W.N. "Western blotting": Electrophoretic transfer of proteins from sodium dodecyl sulfate-Polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 1981, 112, 195-203.
50. Shirwaikar, A.; Rajendran, K.; Barik, R. Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozotocin-nicotinamide induced type-II diabetes mellitus. J. Ethnopharmacol. 2006, 107, 285-290.
51. Ghosh, M.N. Fundamentals of experimental pharmacology. Indian J. Pharmacol. 2007, 39, 216.
52. Turner, R.A.; Hebborn, P. Screening Methods in Pharmacology; Academic Press: New York, NY, USA, 1965; Volume 1; pp. 129-135.
53. Sarkar, S.; Pranava, M.; Marita, R. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol. Res. 1996, 33, 1-4.
54. Sedlak, J.; Lindsay, R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 1968, 25, 192-205.
55. Sinha, A.K. Colorimetric assay of catalase. Anal. Biochem. 1972, 47, 389-394.
56. Draper, H.H.; Hadley, M. Malondialdehyde determination as index of lipid peroxidation. Method. Enzymol. 1990, 186, 421-431.